Cargando…

Molecular mechanism of antibody neutralization of coxsackievirus A16

Coxsackievirus A16 (CVA16) causes hand, foot and mouth disease in infants and young children. However, no vaccine or anti-viral agent is currently available for CVA16. Here, the functions and working mechanisms of two CVA16-specific neutralizing monoclonal antibodies (MAbs), 9B5 and 8C4, are compreh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Chao, Liu, Caixuan, Shi, Jinping, Wang, Yalei, Xu, Cong, Ye, Xiaohua, Liu, Qingwei, Li, Xue, Qiao, Weihua, Yin, Yannan, Cong, Yao, Huang, Zhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769477/ https://www.ncbi.nlm.nih.gov/pubmed/36543790 http://dx.doi.org/10.1038/s41467-022-35575-w

Ejemplares similares

Coxsackievirus A16-like particles elicit neutralizing antibody responses in mice
por: Liu, Qingwei, et al.
Publicado: (2011)

Coxsackievirus A16 utilizes cell surface heparan sulfate glycosaminoglycans as its attachment receptor
por: Zhang, Xueyang, et al.
Publicado: (2017)

In Vitro Characterization of Neutralizing Hen Antibodies to Coxsackievirus A16
por: Mwale, Pharaoh Fellow, et al.
Publicado: (2021)

Construction and characterization of an infectious clone of coxsackievirus A16
por: Liu, Fei, et al.
Publicado: (2011)

Structural Basis for Recognition of Human Enterovirus 71 by a Bivalent Broadly Neutralizing Monoclonal Antibody
por: Ye, Xiaohua, et al.
Publicado: (2016)

Structural basis for SARS-CoV-2 Delta variant recognition of ACE2 receptor and broadly neutralizing antibodies
por: Wang, Yifan, et al.
Publicado: (2022)

Coxsackievirus A10 atomic structure facilitating the discovery of a broad-spectrum inhibitor against human enteroviruses
por: Chen, Jinhuan, et al.
Publicado: (2019)

Development of a Coxsackievirus A16 neutralization assay based on pseudoviruses for measurement of neutralizing antibody titer in human serum
por: Jin, Jun, et al.
Publicado: (2013)

Atomic structures of Coxsackievirus A6 and its complex with a neutralizing antibody
por: Xu, Longfa, et al.
Publicado: (2017)

Coxsackievirus A16 Elicits Incomplete Autophagy Involving the mTOR and ERK Pathways
por: Shi, Yingying, et al.
Publicado: (2015)

Rhombencephalitis and Coxsackievirus A16
por: Goto, Kazuna, et al.
Publicado: (2009)

Development of a pseudovirus based assay for measuring neutralizing antibodies against coxsackievirus B5
por: Chen, Pan, et al.
Publicado: (2017)

A rapid and quantitative assay for measuring neutralizing antibodies of Coxsackievirus B3
por: Chen, Pan, et al.
Publicado: (2016)

VP2 residue N142 of coxsackievirus A10 is critical for the interaction with KREMEN1 receptor and neutralizing antibodies and the pathogenicity in mice
por: Li, Xue, et al.
Publicado: (2023)

Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant
por: Zang, Jinkai, et al.
Publicado: (2022)

Coxsackievirus A16 in Southern Vietnam
por: Nhu, Le Nguyen Truc, et al.
Publicado: (2021)

Non-neutralizing monoclonal antibody targeting VP2 EF loop of Coxsackievirus A16 can protect mice from lethal attack via Fc-dependent effector mechanism
por: Du, Ruixiao, et al.
Publicado: (2022)

Fatal Coxsackievirus A-16 Pneumonitis in Adult
por: Legay, François, et al.
Publicado: (2007)

A human antibody potently neutralizes RSV by targeting the conserved hydrophobic region of prefusion F
por: Yi, Chunyan, et al.
Publicado: (2023)

Anti-Interleukin-16-Neutralizing Antibody Attenuates Cardiac Inflammation and Protects against Cardiac Injury in Doxorubicin-Treated Mice
por: Zhang, Jianwei, et al.
Publicado: (2021)

Neutralizing Antibodies Induced by Recombinant Virus-Like Particles of Enterovirus 71 Genotype C4 Inhibit Infection at Pre- and Post-attachment Steps
por: Ku, Zhiqiang, et al.
Publicado: (2013)

The long non-coding RNA expression profile of Coxsackievirus A16 infected RD cells identified by RNA-seq
por: Shi, Yingying, et al.
Publicado: (2016)

Development and evaluation of an inactivated coxsackievirus A16 vaccine in gerbils
por: Sun, Yi-Sheng, et al.
Publicado: (2022)

Seroepidemiology of human enterovirus71 and coxsackievirusA16 among children in Guangdong province, China
por: Li, Wei, et al.
Publicado: (2013)

Chimeric virus-like particles presenting common neutralizing epitopes of enterovirus 71
por: Wang, Bo, et al.
Publicado: (2011)

Umifenovir Epigenetically Targets the IL-10 Pathway in Therapy against Coxsackievirus B4 Infection
por: Zhang, Shilin, et al.
Publicado: (2022)

Corrigendum to “Anti-Interleukin-16-Neutralizing Antibody Attenuates Cardiac Inflammation and Protects against Cardiac Injury in Doxorubicin-Treated Mice”
por: Zhang, Jianwei, et al.
Publicado: (2022)

Optimization and Characterization of Candidate Strain for Coxsackievirus A16 Inactivated Vaccine
por: Li, Jingliang, et al.
Publicado: (2015)

Evaluation of the cross-neutralization activities elicited by Coxsackievirus A10 vaccine strains
por: Huo, Yaqian, et al.
Publicado: (2021)

Molecular Epidemiology of Coxsackievirus A16: Intratype and Prevalent Intertype Recombination Identified
por: Chen, Xiangpeng, et al.
Publicado: (2013)

Neutralization of interleukin-38 exacerbates coxsackievirus B3-induced acute myocarditis in mice
por: Xue, Yimin, et al.
Publicado: (2021)

A counterintuitive antibody cocktail disrupts coxsackievirus
por: Zost, Seth J., et al.
Publicado: (2022)

Functional epitopes and neutralizing antibodies of vaccinia virus
por: Peng, Fenghao, et al.
Publicado: (2023)

Conformational dynamics of the Beta and Kappa SARS-CoV-2 spike proteins and their complexes with ACE2 receptor revealed by cryo-EM
por: Wang, Yifan, et al.
Publicado: (2021)

Comprehensive profiling of neutralizing polyclonal sera targeting coxsackievirus B3
por: Álvarez-Rodríguez, Beatriz, et al.
Publicado: (2023)

Identification of a neutralizing linear epitope within the VP1 protein of coxsackievirus A10
por: Zhu, Hanyu, et al.
Publicado: (2022)

Molecular epidemiology of coxsackievirus A16 circulating in children in Beijing, China from 2010 to 2019
por: Hu, Ya-Fang, et al.
Publicado: (2021)

Different Antibody Response against the Coxsackievirus A16 VP1 Capsid Protein: Specific or Non-Specific
por: Ding, Yingying, et al.
Publicado: (2016)

Seroepidemiology of Coxsackievirus A6, Coxsackievirus A16, and Enterovirus 71 Infections among Children and Adolescents in Singapore, 2008-2010
por: Ang, Li Wei, et al.
Publicado: (2015)

Circulating Coxsackievirus A16 Identified as Recombinant Type A Human Enterovirus, China
por: Zhao, Ke, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_s0tejfsp27k3h27snoi38j2k5i